BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15593421)

  • 21. Predicting antigenic sites on the foot-and-mouth disease virus capsid of the South African Territories types using virus neutralization data.
    Maree FF; Blignaut B; Esterhuysen JJ; de Beer TAP; Theron J; O'Neill HG; Rieder E
    J Gen Virol; 2011 Oct; 92(Pt 10):2297-2309. PubMed ID: 21697350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative genomics of serotype Asia 1 foot-and-mouth disease virus isolates from India sampled over the last two decades.
    Mohapatra JK; Sanyal A; Hemadri D; Tosh C; Biswas S; Knowles NJ; Rasool TJ; Bandyopadhyay SK; Pattnaik B
    Virus Res; 2008 Sep; 136(1-2):16-29. PubMed ID: 18511143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic and antigenic analysis of two recently circulating genotypes of type A foot-and-mouth disease virus in India: evidence for positive selection in the capsid-coding genes.
    Tosh C; Hemadri D; Sanyal A; Bandyopadhyay SK
    Arch Virol; 2003 May; 148(5):853-69. PubMed ID: 12721795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid Engineering of Foot-and-Mouth Disease Vaccine and Challenge Viruses.
    Lee SY; Lee YJ; Kim RH; Park JN; Park ME; Ko MK; Choi JH; Chu JQ; Lee KN; Kim SM; Tark D; Lee HS; Ko YJ; Seo MG; Park JW; Kim B; Lee MH; Lee JS; Park JH
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28566375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A second RGD motif in the 1D capsid protein of a SAT1 type foot-and-mouth disease virus field isolate is not essential for attachment to target cells.
    Storey P; Theron J; Maree FF; O'Neill HG
    Virus Res; 2007 Mar; 124(1-2):184-92. PubMed ID: 17161881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotype and VP1 gene sequence of a foot-and-mouth disease virus from Hong Kong (2002).
    Feng Q; Chen X; Ma O; Liu Y; Ding M; Collins RA; Ko LS; Xing J; Lau LT; Yu AC; Chen J
    Biochem Biophys Res Commun; 2003 Mar; 302(4):715-21. PubMed ID: 12646228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a conserved linear neutralizing epitope recognized by monoclonal antibody 9A9 against serotype A foot-and-mouth disease virus.
    Liang W; Zhou G; Liu W; Yang B; Li C; Wang H; Yang D; Ma W; Yu L
    Arch Virol; 2016 Oct; 161(10):2705-16. PubMed ID: 27422396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneity and genetic variations of serotypes O and Asia 1 foot-and-mouth disease viruses isolated in Vietnam.
    Le VP; Nguyen T; Park JH; Kim SM; Ko YJ; Lee HS; Nguyen VC; Mai TD; Do TH; Cho IS; Lee KN
    Vet Microbiol; 2010 Oct; 145(3-4):220-9. PubMed ID: 20478669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of suitability of two serotype A candidate vaccine strains for inclusion in FMD vaccine in India.
    Mohapatra JK; Hemadri D; Rao TV; Sreenivasa BP; Subramaniam S; Sanyal A; Periyasamy TR; Singh NK; Pattnaik B; Venkataramanan R
    Vet Microbiol; 2008 Sep; 131(1-2):65-72. PubMed ID: 18394827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of SAT1 type foot-and-mouth disease virus capsid proteins: influence of receptor usage on the properties of virus particles.
    Maree FF; Blignaut B; Aschenbrenner L; Burrage T; Rieder E
    Virus Res; 2011 Feb; 155(2):462-72. PubMed ID: 21167231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic and antigenic analysis of type A foot-and-mouth disease viruses isolated in India during 1987-1996.
    Nayak B; Pattnaik B; Tosh C; Sanyal A; Hemadri D; Patil SS; Venkataramanan R
    Acta Virol; 2001 Feb; 45(1):13-21. PubMed ID: 11394573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence of the coevolution of antigenicity and host cell tropism of foot-and-mouth disease virus in vivo.
    Tami C; Taboga O; Berinstein A; Núñez JI; Palma EL; Domingo E; Sobrino F; Carrillo E
    J Virol; 2003 Jan; 77(2):1219-26. PubMed ID: 12502839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The molecular epidemiology of foot-and-mouth disease virus serotypes A and O from 1998 to 2004 in Turkey.
    Klein J; Parlak U; Ozyörük F; Christensen LS
    BMC Vet Res; 2006 Dec; 2():35. PubMed ID: 17144917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complete nucleotide sequence of a Chinese serotype Asia1 vaccine strain of foot-and-mouth disease virus.
    Du J; Chang H; Cong G; Shao J; Lin T; Shang Y; Liu Z; Liu X; Cai X; Xie Q
    Virus Genes; 2007 Dec; 35(3):635-42. PubMed ID: 17619135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A peptide of foot-and-mouth disease virus serotype Asia1 generating a neutralizing antibody response, and an immunostimulatory peptide.
    Wang JL; Liu MQ; Han J; Chen WZ; Cong W; Cheng G; Gao YH; Lu YG; Chen JL; Zuo XP; Yan WY; Zheng ZX
    Vet Microbiol; 2007 Dec; 125(3-4):224-31. PubMed ID: 17656048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutation in the VP2 gene of P1-2A capsid protein increases the thermostability of virus-like particles of foot-and-mouth disease virus serotype O.
    Ganji VK; Biswal JK; Lalzampuia H; Basagoudanavar SH; Saravanan P; Tamil Selvan RP; Umapathi V; Reddy GR; Sanyal A; Dechamma HJ
    Appl Microbiol Biotechnol; 2018 Oct; 102(20):8883-8893. PubMed ID: 30136205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular characterization of serotype Asia-1 foot-and-mouth disease viruses in Pakistan and Afghanistan; emergence of a new genetic Group and evidence for a novel recombinant virus.
    Jamal SM; Ferrari G; Ahmed S; Normann P; Belsham GJ
    Infect Genet Evol; 2011 Dec; 11(8):2049-62. PubMed ID: 21983559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intra-serotype SAT2 chimeric foot-and-mouth disease vaccine protects cattle against FMDV challenge.
    Maree FF; Nsamba P; Mutowembwa P; Rotherham LS; Esterhuysen J; Scott K
    Vaccine; 2015 Jun; 33(25):2909-16. PubMed ID: 25930116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a universal RT-PCR for amplifying and sequencing the leader and capsid-coding region of foot-and-mouth disease virus.
    Xu L; Hurtle W; Rowland JM; Casteran KA; Bucko SM; Grau FR; Valdazo-González B; Knowles NJ; King DP; Beckham TR; McIntosh MT
    J Virol Methods; 2013 Apr; 189(1):70-6. PubMed ID: 23380590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preserved immunogenicity of an inactivated vaccine based on foot-and-mouth disease virus particles with improved stability.
    Caridi F; Vázquez-Calvo Á; Borrego B; McCullough K; Summerfield A; Sobrino F; Martín-Acebes MA
    Vet Microbiol; 2017 May; 203():275-279. PubMed ID: 28619156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.